Product Categories
| Country: | China |
|---|---|
| Tel: | 13720134139 086-15871494362 |
| Mobile: | 13720134139 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-(2,6-Diethyl-4-methylphenyl)malononitrile | C14H16N2 | 314020-53-6 | Details |
| Pinoxaden | C23H32N2O4 | 243973-20-8 | Details |
| N-(4-Chlorophenyl)hydrazine | C6H7ClN2 | 1073-69-4 | Details |
| 1,4,5-Oxadiazepane dihydrobromide | C4H11BrN2O | 243973-70-8 | Details |
| hexyl (E)-hex-3-enoate | C12H22O2 | 1929579-66-7 | Details |
| Pyraclostrobin | C19H18ClN3O4 | 175013-18-0 | Details |
| 2-(2,6-diethyl-4-methylphenyl)malonamide | C14H20N2O2 | 314020-40-1 | Details |
| 2-Bromo-1,3-diethyl-5-methylbenzene | C11H15Br | 314084-61-2 | Details |
| Estazolam Impurity 6 | C16H12N4 | 30858-50-5 | Details |
| 1-(4-Chlorophenyl)-1H-pyrazol-3-ol | C9H7ClN2O | 76205-19-1 | Details |
| STX-478 | C16H12F5N5O2 | 2883540-92-7 | Details |
| 4-(Isopropylamino)butanol | C7H17NO | 42042-71-7 | Details |
| 4-(Diisopropylamino)butan-1-ol | C10H23NO | 103859-38-7 | Details |
| Ms-PEG2-Ms | C6H14O7S2 | 34604-52-9 | Details |
| GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
| GDC0077 | C18H19F2N5O4 | 2060571-02-8 | Details |
| MBX 8025 | C21H23F3O5S | 851528-79-5 | Details |
| Sofpironium bromide | C22H32BrNO5 | 1628106-94-4 | Details |
| cryptopleurine | C24H27NO3 | 482-22-4 | Details |
| Landiolol | C25H39N3O8 | 133242-30-5 | Details |
| 2-Piperidinecarboxylic acid, 1-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]phenyl]methyl]- | C37H35ClN2O6 | 2447066-00-2 | Details |
| (R)-2-Fluoropropanoic acid | C3H5FO2 | 75244-22-3 | Details |
| (S)-tert-butyl (1-((4-(N-acetoxycarbamimidoyl)benzyl)amino)-1-oxo-3-(3-((2,2,2-trifluoroacetamido)methyl)phenyl)propan-2-yl)carbamate | C27H32F3N5O6 | 1021707-62-9 | Details |
| Azilsartan Impurity A | C25H23N3O4 | 147404-76-0 | Details |
| OPN expression inhibitor 1 | C25H33N3O5 | 2257492-95-6 | Details |
| (RS)-3,5-DHPG | C8H9NO4 | 146255-66-5 | Details |
| MFI-8 | C16H18ClNO | 694488-83-0 | Details |
| Gliocidin | Details |
| 5-Bromo-8-hydroxyquinoline-7-carboxylic acid | C10H6BrNO3 | 205040-59-1 | Details |
| FDW028 | C22H24N6O | 2768426-49-7 | Details |
| SAN50900 | C27H38N8O | 2229050-90-0 | Details |
| PKUMDL-LC-101-D04 HCl | C14H23ClN4O2S2 | 2143896-83-5 | Details |
| BML-284 HCl | C19H19ClN4O3 | 2095432-75-8 | Details |
| BML-284 | C19H18N4O3 | 853220-52-7 | Details |
| 4-Chloro-2,2-diphenylbutanenitrile | C16H14ClN | 68318-96-7 | Details |
| 2,2-Diphenyl-4-(piperidin-1-yl)butanenitrile | C21H24N2 | 5424-08-8 | Details |
| 2-(1H-Pyrazol-1-yl)benzonitrile | C10H7N3 | 25775-03-5 | Details |
| 8-Methylimidazo[1,2-a]pyrazine | C7H7N3 | 91476-79-8 | Details |
| N-(3,4-Dihydroxyphenethyl)methacrylamide | C12H15NO3 | 471915-89-6 | Details |
| Vildagliptin | C17H25N3O2 | 274901-16-5 | Details |
| (E)-3-(4-Acetoxyphenyl)acrylic acid | C11H10O4 | 27542-85-4 | Details |
| Methyl7,7-difluoronorcarane-3-carboxylate | C9H12F2O2 | 1494594-75-0 | Details |
| Bilastine | C28H37N3O3 | 202189-78-4 | Details |
| Dehydronitrosonifedipine | C17H16N2O5 | 50428-14-3 | Details |
| 3-Isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate (Nimodipine Impurity) | C21H24N2O7 | 85677-93-6 | Details |
| Ethyl 5-bromoimidazo[1,2-a]pyridine-2-carboxylate | C10H9BrN2O2 | 135995-46-9 | Details |
| 3-Cyclohexene-1-methanol | C7H12O | 1679-51-2 | Details |
| 6-Chloro-3,4-dihydroquinolin-2(1H)-one | C9H8ClNO | 19358-40-8 | Details |
| 6-Chloro-1,2,3,4-tetrahydroquinoline | C9H10ClN | 49716-18-9 | Details |
| DDO-7263 | C14H9F2N3O | 2254004-96-9 | Details |
| 1-(6-Nitropyridin-3-yl)piperazine | C9H12N4O2 | 775288-71-6 | Details |
| Pyroxamide | C13H19N3O3 | 382180-17-8 | Details |
| 3-(Tert-butylthio)picolinic acid | C10H13NO2S | 178811-41-1 | Details |
| 3-(tert-Butylthio)picolinonitrile | C10H12N2S | 178811-40-0 | Details |
| 1-(Hydroxymethyl)cyclopentane-1-carbonitrile | C7H11NO | 911060-82-7 | Details |
| 7,7-Difluoronorcarane-3-carboxylic acid | C8H10F2O2 | 1909327-73-6 | Details |
| 2-((6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)methyl)benzonitrile | C12H8ClN3O2 | 865758-95-8 | Details |
| Alogliptin | C18H21N5O2 | 850649-61-5 | Details |
| 2-Bromonaphthalen-1-amine | C10H8BrN | 771-14-2 | Details |
| Fenpiverinium Bromide | C22H29BrN2O | 125-60-0 | Details |
| 6-Bromo-8-chloroimidazo[1,2-a]pyrazine | C6H3BrClN3 | 1208083-37-7 | Details |
| 7-Fluorobenzo[b]thiophene-2-carboxylic acid | C9H5FO2S | 550998-67-9 | Details |
| AKT Kinase Inhibitor | C16H19N7O3 | 842148-40-7 | Details |
| AKT Kinase Inhibitor hydrochloride | 3026697-00-4 | Details |
| GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
| (R)-γ-Valerolactone | C5H8O2 | 58917-25-2 | Details |
| Olopatadine Impurity A HCl | C21H24ClNO4 | 1331668-21-3 | Details |
| E-64 | C15H27N5O5 | 66701-25-5 | Details |
| AZD-1152HQPA | C26H30FN7O3 | 722544-51-6 | Details |
| Barasertib | C26H31FN7O6P | 722543-31-9 | Details |
| Biotinyl tyramide | C18H25N3O3S | 41994-02-9 | Details |
| MG115 | C25H39N3O5 | 133407-86-0 | Details |
| Gosogliptin | C17H24F2N6O | 869490-23-3 | Details |
| Eptifibatide | C35H49N11O9S2 | 188627-80-7 | Details |
| Somatostatin Acetate | C76H104N18O19S2 | 51110-01-1 | Details |
| Exenatide Acetate | C186H286N50O62S | 141732-76-5 | Details |
| Cetrorelix acetate | C70H92N17O14 | 130143-01-0 | Details |
| 3X FLAG Peptide | C120H169N31O49S | 402750-12-3 | Details |
| MG-101 | C20H37N3O4 | 110044-82-1 | Details |
| 3-Chloro-n-(4-chlorophenyl)propanamide | C9H9Cl2NO | 19314-16-0 | Details |
| Nordiphenhydramine | C16H19NO | 17471-10-2 | Details |
| PI3K/AKT-IN-1 | C23H23N5O4S | 3033069-84-7 | Details |
| Fenpipramide | C21H26N2O | 77-01-0 | Details |
| Ethyl 1-cyanocyclopentane-1-carboxylate | C9H13NO2 | 28247-14-5 | Details |
| 4-(1-Pyrrolidinyl)-3-(trifluoromethyl)benzoic acid | C12H12F3NO2 | 677704-56-2 | Details |
| 1-Nitro-3-(pentyloxy)benzene | C11H15NO3 | 63929-86-2 | Details |
| 6-Bromo-7-methylindoline-2,3-dione | C9H6BrNO2 | 129833-54-1 | Details |
| N-(3-bromo-2-methylphenyl)-2-hydroxyiminoacetamide | C9H9BrN2O2 | 129833-52-9 | Details |
| Methyl 4-((6-chloro-3,4-dihydroquinolin-1(2h)-yl)methyl)benzoate | C18H18ClNO2 | 2126744-33-8 | Details |
| 5-Bromo-3-fluoro-N-isopropyl-2-nitroaniline | C9H10BrFN2O2 | 2177297-28-6 | Details |
| FSC-231 | C13H10Cl2N2O3 | 1215849-96-9 | Details |
| 2-Methyl-3-(pentyloxy)benzoic acid | C13H18O3 | 1555822-28-0 | Details |
| Nicardipine EP Impurity A | C26H27N3O6 | 59875-58-0 | Details |
| 1-acetylcyclobutane-1-carboxylic acid | C7H10O3 | 639782-98-2 | Details |
| 5-Bromo-3-fluoro-N1-isopropylbenzene-1,2-diamine | C9H12BrFN2 | 2177297-22-0 | Details |
| PT179 | C17H17N3O5 | 2924858-25-1 | Details |
| SDU-071 | C28H25N3O2 | 3036109-10-8 | Details |
| (R)-1-(6-bromo-4-fluoro-1-isopropyl-1H-benzo[d]imidazol-2-yl)ethan-1-ol | C12H14BrFN2O | 2380322-59-6 | Details |
| BBC-0403 | C21H22N2O5 | 2644662-83-7 | Details |
| PKUMDL-LC-101-D04 | C14H22N4O2S2 | 2143896-82-4 | Details |
| Product Total： Product Page： | ||||
| 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 | ||||